Results
1272
Companies which are more than 50% undervalued based on analyst price target.
1,272 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSTR | US$299.69 | -11.3% | 336.0% | US$83.4b | US$513.01 | PS166.4x | E57.1% | n/a | Software | ||
EIX | US$52.17 | 4.2% | -23.6% | US$20.1b | US$78.34 | PE15.3x | E13.5% | 6.3% | Utilities | ||
FSLR | US$155.44 | -2.7% | 8.8% | US$17.6b | US$266.76 | PE13.3x | E24.5% | n/a | Semiconductors | ||
ILMN | US$94.20 | -6.0% | -29.2% | US$15.4b | US$145.92 | PS3.4x | E52.3% | 3.3% | Pharmaceuticals & Biotech | ||
MRNA | US$35.53 | 7.7% | -63.2% | US$13.0b | US$56.51 | PS4.2x | E29.6% | n/a | Pharmaceuticals & Biotech | ||
NBIS | US$39.84 | -10.5% | n/a | US$10.9b | US$59.88 | PS79.8x | n/a | n/a | Software | ||
SRPT | US$106.28 | -1.5% | -22.2% | US$10.4b | US$181.78 | PE83.3x | E30.1% | n/a | Pharmaceuticals & Biotech | ||
PCVX | US$79.74 | -5.1% | 3.7% | US$10.3b | US$149.89 | PB2.9x | E24.4% | n/a | Pharmaceuticals & Biotech | ||
GLOB | US$151.72 | -32.4% | -33.0% | US$9.1b | US$229.95 | PE39.5x | E21.4% | n/a | Software | ||
VFS | US$3.79 | 0.5% | -25.1% | US$9.0b | US$6.33 | PS6.1x | E1.0% | n/a | Automobiles | ||
ONTO | US$159.46 | -9.7% | -10.6% | US$8.3b | US$247.02 | PE39.1x | E26.2% | n/a | Semiconductors | ||
RVMD | US$41.33 | 1.6% | 39.0% | US$7.8b | US$73.29 | PS10293.8x | E20.1% | n/a | Pharmaceuticals & Biotech | ||
CACI | US$327.00 | -3.4% | -11.5% | US$7.7b | US$521.92 | PE15.3x | E8.1% | n/a | Commercial Services | ||
LEGN | US$39.70 | 9.0% | -39.9% | US$7.1b | US$79.50 | PS14x | E56.5% | n/a | Pharmaceuticals & Biotech | ||
CORT | US$63.54 | -12.6% | 183.0% | US$6.8b | US$97.00 | PE47.4x | E38.3% | n/a | Pharmaceuticals & Biotech | ||
KBR | US$49.14 | -5.5% | -17.5% | US$6.8b | US$75.67 | PE20.5x | E22.9% | 1.2% | Commercial Services | ||
PSN | US$59.49 | -19.0% | -25.0% | US$6.6b | US$96.79 | PE27x | E16.9% | n/a | Commercial Services | ||
FRPT | US$106.39 | -19.0% | 17.8% | US$6.3b | US$163.23 | PE110x | E29.7% | n/a | Food, Beverage & Tobacco | ||
CYTK | US$50.26 | 8.9% | -35.6% | US$6.0b | US$79.55 | PS1842.6x | E39.3% | n/a | Pharmaceuticals & Biotech | ||
BILL | US$52.73 | -11.9% | -16.7% | US$5.8b | US$88.40 | PE65.7x | E-8.3% | n/a | Software | ||
LNTH | US$80.84 | -1.4% | 24.3% | US$5.7b | US$133.46 | PE13.1x | E12.8% | n/a | Healthcare | ||
ELAN | US$11.02 | -2.0% | -32.7% | US$5.5b | US$16.75 | PE26.6x | E1.6% | n/a | Pharmaceuticals & Biotech | ||
MARA | US$14.66 | -13.3% | -38.9% | US$5.4b | US$26.92 | PE30.2x | E-36.3% | n/a | Software | ||
ZETA | US$20.73 | -11.7% | 101.3% | US$5.3b | US$36.92 | PS5.5x | E123.5% | n/a | Software |